Short Summary
The Patent Trial and Appeal Board granted institution for multiple IPRs involving Taiwan Semiconductor Manufacturing Company Limited against Marlin Semiconductor Ltd., allowing the merits phase to proceed.
Detailed Summary
In this Institution Decision, the USPTO determined that Taiwan Semiconductor Manufacturing Company Limited had met the requirements under 35 U.S.C. § 314(a) for several Inter Partes Review (IPR) proceedings. The Board found a reasonable likelihood of prevailing with respect to at least one challenged claim in the listed dockets, thereby granting institution and moving the cases forward to the merits phase.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Taiwan Semiconductor Manufacturing Company Limited vs Marlin Semiconductor Ltd. et al. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Google LLCvsVirtaMove, Corp.
Google’s request to rehear the PTAB’s discretionary denial of institution for VirtaMove’s migration patent was rejected. The Director relied on statutory authority and workload considerations to deny institution.
Nike, Inc.vsSherryWear, LLC
Nike and SherryWear reached a confidential settlement, prompting the PTAB to terminate eight related IPRs without deciding the merits.
Apple Inc.vsGinko LLC
Apple Inc.'s IPR petition against Ginko LLC was denied by the PTAB, as the Board found insufficient evidence that cited prior art disclosed the claimed contact permission settings.
Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.
Merck Sharp & Dohme LLC successfully petitioned to institute IPR against Halozyme, Inc.'s patent (12195773) based on grounds of enablement and obviousness. The Board found it likely that the claims defining a vast genus of modified polypeptides are unpatentable due to insufficient disclosure regarding solubility and activity prediction.
Mercedes-Benz Group AG et al.vsPhelan Group, LLC
Mercedes‑Benz and The Phelan Group jointly filed a motion to keep their settlement agreement confidential under 35 U.S.C. § 317(b) and to terminate the ongoing IPR. The Board is asked to seal the agreement from public disclosure.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.